I don’t want to come across as a know-it-all at this point. But after my remarks on the Mollii Suit have caused excitement, I would like to briefly address the most recent court rulings on
Continue reading
Where does conventional medicine end, where do alternative healing methods begin? This article and video deal with evidence-based medicine, alternative methods and the role of the psyche in the development of MS. Prof. Mathias Mäurer
Continue reading
The Epstein-Barr virus (EBV) persists for life in the human body after a primary infection. Most often, the infection has no consequences, but the virus can also cause severe illness and is associated with the
Continue reading
There were two important highlights at the ECTRIMS Congress 2024 in Copenhagen: The Bruton tyrosine kinase inhibitor (BTKi) Tolebrutinib was able to show in Phase 3 that it significantly slows the progression of disability in
Continue reading
Prof. Mathias Mäurer discusses in this video about the new form of therapy and the current status of results on CAR-T cell therapy for MS. Please consider using the automated translation of YouTube. You can
Continue reading
Currently, reports from the UK are causing a stir. The reason is data from the British statistical authority, according to which there have been increasing deaths in connection with the intake of Pregabalin from 2018
Continue reading
This year’s annual meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) took place from October 12 to 14 in Milan. This most important scientific MS congress discusses the most important
Continue reading Vidofludimus Calcium (IMU838) is a new, selective inhibitor of the enzyme dihydroorotate dehydrogenase (DHODH) from the biotech company Immunic Therapeutics. The manufacturer is currently testing it in patients with relapsing-remitting multiple sclerosis in a phase
Continue reading
Natalizumab (Tysabri®) inhibits the migration (transmigration) of inflammatory cells into the central nervous system and was the first monoclonal antibody approved for the treatment of relapsing multiple sclerosis.
Continue reading Cladribine is a prodrug, which is activated after being inserted into body cells and incorporated into the DNA of cells as a so-called nucleoside analogue. This integration leads to programmed cell death.
Continue reading
Unsere Website verwendet Cookies und sammelt dabei Informationen über Ihren Besuch, um unsere Website zu verbessern (durch Analyse), Ihnen Social Media-Inhalte und relevante Werbung anzuzeigen. Weitere Informationen finden Sie auf unserer Seite . Sie können zustimmen, indem Sie auf die Schaltfläche "Akzeptieren" klicken.
Cookie-Einstellungen
Unten können Sie auswählen, welche Art von Cookies Sie auf dieser Website zulassen. Klicken Sie auf die Schaltfläche "Cookie-Einstellungen speichern", um Ihre Auswahl zu übernehmen.
Dieser Inhalt ist gesperrt. Akzeptieren Sie Cookies in der Kategorie '%CC%', um diesen Inhalt anzuzeigen.
